Literature DB >> 12423093

Caminoside A, an antimicrobial glycolipid isolated from the marine sponge Caminus sphaeroconia.

Roger G Linington1, Marilyn Robertson, Annick Gauthier, B Brett Finlay, Rob van Soest, Raymond J Andersen.   

Abstract

Extracts of the marine sponge Caminus sphaeroconia showed potent activity in a screen for bacterial type III secretion inhibitors. Bioassay guided fractionation of the extract led to the isolation of the novel antimicrobial glycolipid caminoside A (1). The structure of caminoside A was elucidated by analysis of spectroscopic data and chemical degradation.[structure: see text]

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12423093     DOI: 10.1021/ol0268337

Source DB:  PubMed          Journal:  Org Lett        ISSN: 1523-7052            Impact factor:   6.005


  25 in total

1.  Small-molecule inhibitors specifically targeting type III secretion.

Authors:  R Nordfelth; A M Kauppi; H A Norberg; H Wolf-Watz; M Elofsson
Journal:  Infect Immun       Date:  2005-05       Impact factor: 3.441

2.  Transcriptional inhibitor of virulence factors in enteropathogenic Escherichia coli.

Authors:  Annick Gauthier; Marilyn L Robertson; Michael Lowden; J Antonio Ibarra; José Luis Puente; B Brett Finlay
Journal:  Antimicrob Agents Chemother       Date:  2005-10       Impact factor: 5.191

Review 3.  Marine pharmacology in 2001--2002: marine compounds with anthelmintic, antibacterial, anticoagulant, antidiabetic, antifungal, anti-inflammatory, antimalarial, antiplatelet, antiprotozoal, antituberculosis, and antiviral activities; affecting the cardiovascular, immune and nervous systems and other miscellaneous mechanisms of action.

Authors:  Alejandro M S Mayer; Mark T Hamann
Journal:  Comp Biochem Physiol C Toxicol Pharmacol       Date:  2005 Mar-Apr       Impact factor: 3.228

Review 4.  Antimicrobial Lipids from Plants and Marine Organisms: An Overview of the Current State-of-the-Art and Future Prospects.

Authors:  Eliana Alves; Marina Dias; Diana Lopes; Adelaide Almeida; Maria do Rosário Domingues; Felisa Rey
Journal:  Antibiotics (Basel)       Date:  2020-07-24

Review 5.  Possible drugs for the treatment of bacterial infections in the future: anti-virulence drugs.

Authors:  Hiroshi Ogawara
Journal:  J Antibiot (Tokyo)       Date:  2020-07-09       Impact factor: 2.649

Review 6.  Chemical inhibitors of the type three secretion system: disarming bacterial pathogens.

Authors:  Miles C Duncan; Roger G Linington; Victoria Auerbuch
Journal:  Antimicrob Agents Chemother       Date:  2012-07-30       Impact factor: 5.191

7.  The bacterial type III secretion system as a target for developing new antibiotics.

Authors:  Andrew C McShan; Roberto N De Guzman
Journal:  Chem Biol Drug Des       Date:  2015-01       Impact factor: 2.817

8.  Cytosporone B, an inhibitor of the type III secretion system of Salmonella enterica serovar Typhimurium.

Authors:  Jianfang Li; Chao Lv; Weiyang Sun; Zhenyu Li; Xiaowei Han; Yaoyao Li; Yuemao Shen
Journal:  Antimicrob Agents Chemother       Date:  2013-03-04       Impact factor: 5.191

9.  An inhibitor of gram-negative bacterial virulence protein secretion.

Authors:  Heather B Felise; Hai V Nguyen; Richard A Pfuetzner; Kathleen C Barry; Stona R Jackson; Marie-Pierre Blanc; Philip A Bronstein; Toni Kline; Samuel I Miller
Journal:  Cell Host Microbe       Date:  2008-10-16       Impact factor: 21.023

10.  Substituted 2-imino-5-arylidenethiazolidin-4-one inhibitors of bacterial type III secretion.

Authors:  Toni Kline; Heather B Felise; Kathleen C Barry; Stona R Jackson; Hai V Nguyen; Samuel I Miller
Journal:  J Med Chem       Date:  2008-11-27       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.